Document

Cannabis Investment Report | December 2017

Ref IMAGES-008-HOUSE_OVERSIGHT_024766.txt Release House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pages

Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.

View the original on the official release

People & organizations named in this document

Being named here is not an accusation of wrongdoing.

Document text

Text is machine OCR and may contain errors. Confirm against the original source above.

ACKRELL CAPITAL Cannabis Investment Report | December 2017 Toronto Stock Exchange ($U.S. millions, except stock price) LTM Forward Forward EV Revenue EBITDA Stock % Below . : . Price 52-Week Market Enterprise LTM LTM Multiples __Muttiples Multiples Company Ticker 11/30/17 High Value Value(EV) Revenue EBITDA Revenue EBITDA 2018 2019 2018 2019 Aphria Inc. TSX:APH $8.91 9.9% $1,350.2 $1,281.7 $17.7 $3.8 724x NM 37.7x 9.9x NM 27.5x Aurora Cannabis Inc. TSX:ACB 6.21 7.6% 2,483.5 2,406.8 18.6 -47 NM NM 48.6 13.6 NM 30.4 CanniMed Therapeutics Inc. | TSX:CMED 15:15 10.9% 347.8 315.8 12.0 2.0 26.3 NM 10.6 54 48.5x 13.3 Canopy Growth Corporation TSX:WEED 14.30 15.1% 2,720.6 2,641.7 46.3 19 57.1 NM 39.7 11.7 NM NM MedReleaf Corp. TSX:LEAF 12.66 13.7% 1,146.2 1,094.8 32.9 97 S615 NM 30.8 9.4 NM 27.0 Neptune Technologies 8 TS y.NEPT 154 16.0% 120.8 127.4 324 37 3.9 NM 6.0 43 NM NM Bioressources Inc. Median 12.3% $1,248.2 $1,188.3 -$0.1 33.3x TSX Venture Exchange ($U.S. millions, except stock price) LTM Forward Forward Stock %Below EV Revenue EBITDA Price 52-Week Market Enterprise LTM LTM Multiples Multiples —Mittiples Company Ticker 11/30/17 High Value Value(EV) Revenue EBITDA Revenue EBITDA _ 2018 _2019 2018 2019 ABcann Global Corporation SXV:ABCN $1.13 19.9% $152.7 $129.7 $0.7 -$8.7 NM NM 11.2x 2.6% NM 9.2x Cannabis Wheaton Income SXV:CBW 0.68 56.5% 157.2 157.0 01 -6.2 NM NM NA NA NA NA Cronos Group Inc. SXV:MJN 3.38 9.0% 503.2 494.0 23. 25 NM NM 16.1 5.8 NM 17.6 Delta 9 Cannabis Inc. SXV:NINE 2.37 23.8% 143.9 145.5 04 -17 NM NM NA NA NA NA Emblem Corp. SXV:EMC 1.26 64.6% 117.1 108.0 1.8 -75 59.4x NM 10.5 2.0 NA 5.6 Emerald Health Therapeutics TSXV:EMH 2.27 4.6% 213.8 195.6 0.6 -43 NM NM 46.6 NA NA NA Harvest One Cannabis Inc. SXV:HVST 0.71 18.6% 63.7 54.1 0.2 -45 NM NM 17.0 18 NA 9.2 Hempco Food and Fiber Inc. TSXV:HEMP 1.66 31.6% 15 774 47 -1.3 16.5 NM NA NA NA NA CC International Cannabis SXV:ICC 0.76 44.3% 104.6 102.5 01 -45 NM NM 64 14 NM 4.0 nvictus MD Strategies Corp. TSXV:IMH 142 33.6% 89.6 66.7 1.8 -10.3 37.6 NM 213 3.6 NM 13.3 LGC Capital Ltd. SXV:LG 0.29 24.0% 79.6 76.6 0.0 -17 NM NM NA NA NA NA Maple Leaf Green World Inc. TSXV:MGW 0.46 24.4% 67.3 64.2 04 -14 NM NM NA NA NA NA National Access Clinic Corp. © TSXV:NAC 0.40 30.1% 24.0 25.0 07 -2.4 36.7 NM NA NA NA NA Naturally Splendid Enter. SXV:NSP 0.21 45.0% 20.4 20.9 19 -43 10.9 NM NA NA NA NA Newstrike Resources Ltd. SXV:HIP 0.39 16.7% 151.1 152.1 0.0 -0.3 NM NM NA NA NA NA OrganiGram Holdings Inc. SXV:0GI 2.61 15.7% 2774 244.2 40 -5.2 60.7 NM 97 34 46.5x 12.6 Tetra Bio-Pharma Inc. SXV:TBP 0.54 14.8% 63.6 62.0 0.0 -3.9 NM NM NA NA NA NA The Hydrapothecary Corp. SXV:THCX 192 17.7% 149.8 168.3 3.3 -0.6 40.7 NM 15.8 3.6 NM 29.8 Viridium Pacific Group Ltd. SXVVIR 1.09 15.2% 49.5 48.6 0.0 -0.1 NM NM NA NA NA NA WeedMD Inc. SXV:WMD 1.69 12.8% 123.2 121.0 0.5 -3.1 NM NM oto) 23 NM 8.6 21.8% $110.8 $105.3 Source: S&P Global Market Intelligence. Not Meaningful (NM) used for negative multiples, and for revenue multiples greater than 100.0x and EBITDA multiples greater than 50.0x. Not Available (NA) used for information that is not available. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization. 130 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC HOUSE_OVERSIGHT_024766

Have a question about what this document contains?

Ask the documents